18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028
18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028
Recruiting · NCT05520255 · Registry updated 2026-09-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028 | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2026-09-24 | NCT05520255 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Alberta | 249 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Alberta | Edmonton | Canada | 23 |